Effect of pressure overload on cardioprotection of mitochondrial K ATP channels and GSK-3β

Interaction with the MPT pore

Mahmood S Mozaffari, Stephen W. Schaffer

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: The mitochondrial permeability transition (MPT) pore may serve as the end-effector of cardioprotective mechanisms, namely the mitochondrial KATP channels and glycogen synthase kinase-3β (GSK-3β). We recently showed that augmented MPT pore induction contributes to pressure overload-induced exacerbation of infarct size. This study tests the hypotheses that (i) elevation in perfusion pressure attenuates cardioprotection associated with activation of mitochondrial KATP channels or inhibition of GSK-3β and (ii) perfusion pressure modulates the regulation of the MPT pore by mitochondrial KATP channels and/or GSK-3β. Methods: Langendorff-perfused hearts were subjected to a regional ischemia-reperfusion insult at a perfusion pressure of either 80 or 160 cm H2O. The perfusion medium contained no drug, diazoxide (80 μmol/l; mitochondrial KATP channel opener), lithium chloride (LiCl, 1 mmol/l; nonselective inhibitor of GSK-3β), SB-216763 (3 μmol/l; selective inhibitor of GSK-3β), cyclosporine A (0.2 μmol/l; inhibitor of MPT pore induction), glibenclamide (50 μmol/l; inhibitor of KATP channels), and the combination of cyclosporine A and glibenclamide or the combination of glibenclamide and LiCl. Results: The increase in perfusion pressure in the absence of a drug caused larger infarcts, an effect associated with poorer recovery of function following ischemia reperfusion. Treatment with either diazoxide or cyclosporine A reduced infarct size at both perfusion pressures but in contrast to diazoxide, cyclosporine A was more protective at the higher pressure. On the other hand, LiCl and SB-216763 reduced infarct size at both pressures, with the effect more marked at the higher perfusion pressure. Glibenclamide did not affect infarct size but eliminated the cardioprotective effect of cyclosporine A while having no effect on LiCl-induced cardioprotection. Conclusion: Perfusion pressure primarily affects GSK-3β-mediated regulation of MPT pore formation in the ischemic reperfused heart.

Original languageEnglish (US)
Pages (from-to)570-575
Number of pages6
JournalAmerican journal of hypertension
Volume21
Issue number5
DOIs
StatePublished - May 1 2008

Fingerprint

Glycogen Synthase Kinase 3
Pressure
Perfusion
Glyburide
Cyclosporine
Diazoxide
Reperfusion
Ischemia
mitochondrial K(ATP) channel
mitochondrial permeability transition pore
Lithium Chloride
KATP Channels
Recovery of Function
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effect of pressure overload on cardioprotection of mitochondrial K ATP channels and GSK-3β : Interaction with the MPT pore. / Mozaffari, Mahmood S; Schaffer, Stephen W.

In: American journal of hypertension, Vol. 21, No. 5, 01.05.2008, p. 570-575.

Research output: Contribution to journalArticle

@article{b5e42d57432041dc845ae12df52edfbc,
title = "Effect of pressure overload on cardioprotection of mitochondrial K ATP channels and GSK-3β: Interaction with the MPT pore",
abstract = "Background: The mitochondrial permeability transition (MPT) pore may serve as the end-effector of cardioprotective mechanisms, namely the mitochondrial KATP channels and glycogen synthase kinase-3β (GSK-3β). We recently showed that augmented MPT pore induction contributes to pressure overload-induced exacerbation of infarct size. This study tests the hypotheses that (i) elevation in perfusion pressure attenuates cardioprotection associated with activation of mitochondrial KATP channels or inhibition of GSK-3β and (ii) perfusion pressure modulates the regulation of the MPT pore by mitochondrial KATP channels and/or GSK-3β. Methods: Langendorff-perfused hearts were subjected to a regional ischemia-reperfusion insult at a perfusion pressure of either 80 or 160 cm H2O. The perfusion medium contained no drug, diazoxide (80 μmol/l; mitochondrial KATP channel opener), lithium chloride (LiCl, 1 mmol/l; nonselective inhibitor of GSK-3β), SB-216763 (3 μmol/l; selective inhibitor of GSK-3β), cyclosporine A (0.2 μmol/l; inhibitor of MPT pore induction), glibenclamide (50 μmol/l; inhibitor of KATP channels), and the combination of cyclosporine A and glibenclamide or the combination of glibenclamide and LiCl. Results: The increase in perfusion pressure in the absence of a drug caused larger infarcts, an effect associated with poorer recovery of function following ischemia reperfusion. Treatment with either diazoxide or cyclosporine A reduced infarct size at both perfusion pressures but in contrast to diazoxide, cyclosporine A was more protective at the higher pressure. On the other hand, LiCl and SB-216763 reduced infarct size at both pressures, with the effect more marked at the higher perfusion pressure. Glibenclamide did not affect infarct size but eliminated the cardioprotective effect of cyclosporine A while having no effect on LiCl-induced cardioprotection. Conclusion: Perfusion pressure primarily affects GSK-3β-mediated regulation of MPT pore formation in the ischemic reperfused heart.",
author = "Mozaffari, {Mahmood S} and Schaffer, {Stephen W.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1038/ajh.2008.25",
language = "English (US)",
volume = "21",
pages = "570--575",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Effect of pressure overload on cardioprotection of mitochondrial K ATP channels and GSK-3β

T2 - Interaction with the MPT pore

AU - Mozaffari, Mahmood S

AU - Schaffer, Stephen W.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Background: The mitochondrial permeability transition (MPT) pore may serve as the end-effector of cardioprotective mechanisms, namely the mitochondrial KATP channels and glycogen synthase kinase-3β (GSK-3β). We recently showed that augmented MPT pore induction contributes to pressure overload-induced exacerbation of infarct size. This study tests the hypotheses that (i) elevation in perfusion pressure attenuates cardioprotection associated with activation of mitochondrial KATP channels or inhibition of GSK-3β and (ii) perfusion pressure modulates the regulation of the MPT pore by mitochondrial KATP channels and/or GSK-3β. Methods: Langendorff-perfused hearts were subjected to a regional ischemia-reperfusion insult at a perfusion pressure of either 80 or 160 cm H2O. The perfusion medium contained no drug, diazoxide (80 μmol/l; mitochondrial KATP channel opener), lithium chloride (LiCl, 1 mmol/l; nonselective inhibitor of GSK-3β), SB-216763 (3 μmol/l; selective inhibitor of GSK-3β), cyclosporine A (0.2 μmol/l; inhibitor of MPT pore induction), glibenclamide (50 μmol/l; inhibitor of KATP channels), and the combination of cyclosporine A and glibenclamide or the combination of glibenclamide and LiCl. Results: The increase in perfusion pressure in the absence of a drug caused larger infarcts, an effect associated with poorer recovery of function following ischemia reperfusion. Treatment with either diazoxide or cyclosporine A reduced infarct size at both perfusion pressures but in contrast to diazoxide, cyclosporine A was more protective at the higher pressure. On the other hand, LiCl and SB-216763 reduced infarct size at both pressures, with the effect more marked at the higher perfusion pressure. Glibenclamide did not affect infarct size but eliminated the cardioprotective effect of cyclosporine A while having no effect on LiCl-induced cardioprotection. Conclusion: Perfusion pressure primarily affects GSK-3β-mediated regulation of MPT pore formation in the ischemic reperfused heart.

AB - Background: The mitochondrial permeability transition (MPT) pore may serve as the end-effector of cardioprotective mechanisms, namely the mitochondrial KATP channels and glycogen synthase kinase-3β (GSK-3β). We recently showed that augmented MPT pore induction contributes to pressure overload-induced exacerbation of infarct size. This study tests the hypotheses that (i) elevation in perfusion pressure attenuates cardioprotection associated with activation of mitochondrial KATP channels or inhibition of GSK-3β and (ii) perfusion pressure modulates the regulation of the MPT pore by mitochondrial KATP channels and/or GSK-3β. Methods: Langendorff-perfused hearts were subjected to a regional ischemia-reperfusion insult at a perfusion pressure of either 80 or 160 cm H2O. The perfusion medium contained no drug, diazoxide (80 μmol/l; mitochondrial KATP channel opener), lithium chloride (LiCl, 1 mmol/l; nonselective inhibitor of GSK-3β), SB-216763 (3 μmol/l; selective inhibitor of GSK-3β), cyclosporine A (0.2 μmol/l; inhibitor of MPT pore induction), glibenclamide (50 μmol/l; inhibitor of KATP channels), and the combination of cyclosporine A and glibenclamide or the combination of glibenclamide and LiCl. Results: The increase in perfusion pressure in the absence of a drug caused larger infarcts, an effect associated with poorer recovery of function following ischemia reperfusion. Treatment with either diazoxide or cyclosporine A reduced infarct size at both perfusion pressures but in contrast to diazoxide, cyclosporine A was more protective at the higher pressure. On the other hand, LiCl and SB-216763 reduced infarct size at both pressures, with the effect more marked at the higher perfusion pressure. Glibenclamide did not affect infarct size but eliminated the cardioprotective effect of cyclosporine A while having no effect on LiCl-induced cardioprotection. Conclusion: Perfusion pressure primarily affects GSK-3β-mediated regulation of MPT pore formation in the ischemic reperfused heart.

UR - http://www.scopus.com/inward/record.url?scp=42549138502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549138502&partnerID=8YFLogxK

U2 - 10.1038/ajh.2008.25

DO - 10.1038/ajh.2008.25

M3 - Article

VL - 21

SP - 570

EP - 575

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 5

ER -